September 13, 2026
Business Standard highlighted a decline in antibiotic sales in India, while raising concerns that lower consumption does not necessarily indicate more appropriate antibiotic use.
The article drew on insights from OHT’s Dr. Ramanan Laxminarayan, who emphasized that India’s antibiotic use remains skewed toward second-line antibiotics, with some potentially being used unnecessarily while access to the right antibiotics remains limited.
Read the article here
